| Milton Oludhe Ochieng', MD | |
|
20 Progress Point Pkwy, Ste 108, O Fallon, MO 63368-2206 | |
| (636) 344-1073 | |
| (636) 344-1075 |
| Full Name | Milton Oludhe Ochieng' |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 16 Years |
| Location | 20 Progress Point Pkwy, O Fallon, Missouri |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477717080 | NPI | - | NPPES |
| 1477717080 | Other | MO | NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 2014012514 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Blessing Hospital | Quincy, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Blessing Hospital | 3072422534 | 345 |
News Archive
The first evidence of a distinctive protein signature that could help to transform the diagnosis and improve the monitoring of the devastating lung disease idiopathic pulmonary fibrosis (IPF) is being reported by University of Pittsburgh School of Medicine researchers in this month's edition of PLoS Medicine, an open-access journal of the Public Library of Science.
PaxVax, Inc., which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner, today announced positive results in a Phase 1 clinical trial for its oral, replicating adenovirus serotype 4 (Ad4) vector vaccine for H5N1 (avian flu).
Cappella, Inc. (Cappella), a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, promoted their serial IVUS analysis & Sideguard® 3.25 device during the Joint Interventional Meeting (JIM) in Rome. Gary S. Mintz, MD, Cardiovascular Research Foundation, New York, USA presented "Positive Vessel Remodeling Using Sideguard in Coronary Bifurcations" during the New Technologies 1 Symposium.
Unless Ebola control measures in West Africa are enhanced quickly, experts from the World Health Organization and Imperial College, London, predict numbers will continue to climb exponentially, and more than 20,000 people will have been infected by early November, according to a new article in the New England Journal of Medicine released six months after WHO was first notified of the outbreak in West Africa.
› Verified 2 days ago
| Entity Name | Blessing Hospital |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1114471737 PECOS PAC ID: 3072422534 Enrollment ID: O20161005001836 |
News Archive
The first evidence of a distinctive protein signature that could help to transform the diagnosis and improve the monitoring of the devastating lung disease idiopathic pulmonary fibrosis (IPF) is being reported by University of Pittsburgh School of Medicine researchers in this month's edition of PLoS Medicine, an open-access journal of the Public Library of Science.
PaxVax, Inc., which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner, today announced positive results in a Phase 1 clinical trial for its oral, replicating adenovirus serotype 4 (Ad4) vector vaccine for H5N1 (avian flu).
Cappella, Inc. (Cappella), a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, promoted their serial IVUS analysis & Sideguard® 3.25 device during the Joint Interventional Meeting (JIM) in Rome. Gary S. Mintz, MD, Cardiovascular Research Foundation, New York, USA presented "Positive Vessel Remodeling Using Sideguard in Coronary Bifurcations" during the New Technologies 1 Symposium.
Unless Ebola control measures in West Africa are enhanced quickly, experts from the World Health Organization and Imperial College, London, predict numbers will continue to climb exponentially, and more than 20,000 people will have been infected by early November, according to a new article in the New England Journal of Medicine released six months after WHO was first notified of the outbreak in West Africa.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Milton Oludhe Ochieng', MD 20 Progress Point Pkwy Ste 206, O Fallon, MO 63368-2207 Ph: (636) 344-1073 | Milton Oludhe Ochieng', MD 20 Progress Point Pkwy, Ste 108, O Fallon, MO 63368-2206 Ph: (636) 344-1073 |
News Archive
The first evidence of a distinctive protein signature that could help to transform the diagnosis and improve the monitoring of the devastating lung disease idiopathic pulmonary fibrosis (IPF) is being reported by University of Pittsburgh School of Medicine researchers in this month's edition of PLoS Medicine, an open-access journal of the Public Library of Science.
PaxVax, Inc., which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner, today announced positive results in a Phase 1 clinical trial for its oral, replicating adenovirus serotype 4 (Ad4) vector vaccine for H5N1 (avian flu).
Cappella, Inc. (Cappella), a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, promoted their serial IVUS analysis & Sideguard® 3.25 device during the Joint Interventional Meeting (JIM) in Rome. Gary S. Mintz, MD, Cardiovascular Research Foundation, New York, USA presented "Positive Vessel Remodeling Using Sideguard in Coronary Bifurcations" during the New Technologies 1 Symposium.
Unless Ebola control measures in West Africa are enhanced quickly, experts from the World Health Organization and Imperial College, London, predict numbers will continue to climb exponentially, and more than 20,000 people will have been infected by early November, according to a new article in the New England Journal of Medicine released six months after WHO was first notified of the outbreak in West Africa.
› Verified 2 days ago
Brian A Grus, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 20 Progress Point Pkwy Ste 108, O Fallon, MO 63368 Phone: 636-344-2400 | |
Alexander Marinov Markov, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 20 Progress Point Pkwy Ste 200, O Fallon, MO 63368 Phone: 636-916-9615 | |
Nadia Zia, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2 Progress Point Ct, O Fallon, MO 63368 Phone: 314-317-0600 Fax: 314-317-0606 | |
Dr. Amy Kathleen Davis, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1008 Rock Creek Elementary School Dr, O Fallon, MO 63366 Phone: 636-281-4410 Fax: 636-281-4412 | |
Dr. Saadia Taufiq Raza, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 6704 Keaton Corp Pkwy, O Fallon, MO 63368 Phone: 636-300-9596 Fax: 636-300-9598 | |
Dr. Genevieve Catherine Matthews, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 20 Progress Point Pkwy Ste 108, O Fallon, MO 63368 Phone: 636-344-2400 Fax: 636-344-2401 | |
Neal Holzum, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2 Progress Point Ct, Ste 101a, O Fallon, MO 63368 Phone: 636-236-9945 |